This Crispr Therapeutics Stock: Why It Fell Today So Far
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
This intro explains what a high index level may indicate in terms of trend strength, momentum, and potential market overheating.
25,925 articlesBiotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
A new executive directive directs the Federal Reserve to reassess whether non-bank fintech and crypto firms can acces...
Rocket Lab is pursuing a bold $8 billion strategy to merge rocket launches, satellites, and data services. Learn what...
One staffing stock plunged 56% in the last year, but a large new stake worth almost $10 million could signal a forthc...
When a company reports Q1 2026 results, the earnings call is where plans meet numbers. This guide explains how to rea...
The AI boom relies on more than chips. It hinges on the invisible backbone—equipment that enables chipmakers to scale...
When a high profile government move hits a new domain in the headlines, markets pay attention. This piece breaks down...
A high-profile crypto exposure is more than a headline. This deep dive unpacks what trump media moves over Bitcoin be...
A high-profile casting announcement isn’t just entertainment news. It reveals how budgets, marketing, and risk affect...
A notable fund exited its position in a medical device stock, locking in gains as the shares slipped over the past ye...
This earnings season produced a mix of wins and misses. We break down what worked what didn't, with actionable tips y...
Rivian surprised investors with higher-than-expected Q2 deliveries and a raised full-year delivery outlook. This arti...